Q: Q4. Match the following:\n(a) Plasmid (i) selectable marker\n(b) Exonuclease (ii) making cuts at specific positions\n(c) Restriction endonuclease (iii) outside the DNA\n(d) Ligase (iv)

Here are the correct matches:\n\n(a) **Plasmid** - (v) Extrachromosomal DNA\n(b) **Exonuclease** - (iii) outside the DNA\n(c) **Restriction endonuclease** - (ii) making cuts at specific positions\n(d) **Ligase** - (iv) joining of DNA fragments\n(e) **EcoRI** - (ii) making cuts at specific positions (EcoRI is a type of restriction endonuclease)\n(f) **pBR322** - (vi) vector (pBR322 is a commonly used plasmid vector)

Question 1

Q1. Can you list 10 recombinant proteins which are used in medical practice? Find out where they are used as therapeutics (use the internet).

Accepted Answer

Recombinant proteins are proteins produced using recombinant DNA technology, often in host organisms like bacteria, yeast, or mammalian cells. They have revolutionized medical practice by providing safe and effective therapeutic agents. Here are 10 recombinant proteins and their therapeutic uses:

1.  **Human Insulin (Humulin)**
    *   **Therapeutic Use:** Treatment of Type 1 and Type 2 diabetes mellitus. It helps regulate blood glucose levels by promoting glucose uptake by cells.

2.  **Human Growth Hormone (Somatotropin)**
    *   **Therapeutic Use:** Treatment of growth hormone deficiency in children (leading to dwarfism) and adults, Turner syndrome, and chronic kidney disease.

3.  **Erythropoietin (EPO)**
    *   **Therapeutic Use:** Treatment of anemia, especially in patients with chronic kidney failure, cancer patients undergoing chemotherapy, and HIV patients. It stimulates red blood cell production.

4.  **Interferon-alpha (IFN-α)**
    *   **Therapeutic Use:** Treatment of chronic hepatitis B and C, certain cancers (e.g., hairy cell leukemia, Kaposi's sarcoma), and multiple sclerosis. It has antiviral and anti-proliferative effects.

5.  **Interferon-beta (IFN-β)**
    *   **Therapeutic Use:** Treatment of relapsing forms of multiple sclerosis. It helps reduce the frequency and severity of relapses.

6.  **Tissue Plasminogen Activator (tPA)**
    *   **Therapeutic Use:** Treatment of acute myocardial infarction (heart attack), ischemic stroke, and pulmonary embolism. It helps dissolve blood clots.

7.  **Factor VIII (Recombinant)**
    *   **Therapeutic Use:** Treatment and prevention of bleeding episodes in patients with Hemophilia A, a genetic bleeding disorder caused by a deficiency of clotting factor VIII.

8.  **Factor IX (Recombinant)**
    *   **Therapeutic Use:** Treatment and prevention of bleeding episodes in patients with Hemophilia B, a genetic bleeding disorder caused by a deficiency of clotting factor IX.

9.  **Hepatitis B Vaccine (Recombinant)**
    *   **Therapeutic Use:** Prevention of Hepatitis B infection. It consists of recombinant Hepatitis B surface antigen (HBsAg) which elicits an immune response.

10. **Granulocyte Colony-Stimulating Factor (G-CSF)**
    *   **Therapeutic Use:** Treatment of neutropenia (low neutrophil count) caused by chemotherapy, bone marrow transplantation, or other conditions. It stimulates the production of neutrophils, a type of white blood cell.

Question 2

Q2. Make a flow chart of the production of a recombinant human insulin (use the information given in your textbook).

Accepted Answer

The production of recombinant human insulin (Humulin) was a landmark achievement in biotechnology, pioneered by Eli Lilly in 1983. The process involves synthesizing the A and B peptide chains of human insulin separately and then joining them. Here is a detailed description of the steps, which can be represented as a flowchart:

**Flowchart for the Production of Recombinant Human Insulin**

1.  **Identification and Synthesis of Insulin Gene Chains:**
    *   The mature human insulin molecule consists of two short polypeptide chains: Chain A (21 amino acids) and Chain B (30 amino acids), linked by disulfide bonds. It is initially synthesized as a pro-hormone (proinsulin) with an additional C-peptide.
    *   Instead of directly cloning the proinsulin gene (which would require complex post-translational processing in bacteria), the genes encoding the A-chain and B-chain of human insulin are chemically synthesized separately.

2.  **Cloning into Plasmid Vectors:**
    *   Each synthetic gene (for A-chain and B-chain) is then independently inserted into a separate plasmid vector (e.g., pBR322 or a similar expression vector).
    *   Crucially, these genes are inserted adjacent to a bacterial gene (e.g., lacZ gene or β-galactosidase gene) in the plasmid. This ensures that the insulin chains are produced as fusion proteins, which helps in their stability and expression in the bacterial host.

3.  **Transformation of Host Bacteria (E. coli):**
    *   The recombinant plasmids, one carrying the A-chain gene and the other carrying the B-chain gene, are introduced into two separate cultures of *Escherichia coli* (E. coli) bacteria through a process called transformation.
    *   E. coli is a preferred host due to its rapid growth, ease of genetic manipulation, and high protein expression capabilities.

4.  **Culturing and Expression in Bioreactors:**
    *   The transformed E. coli cells are then grown in large-scale bioreactors under optimal conditions (temperature, pH, nutrients, aeration).
    *   As the bacteria multiply, they express the recombinant genes, leading to the production of the A-chain fusion protein in one culture and the B-chain fusion protein in the other.

5.  **Extraction and Purification of Chains:**
    *   After sufficient protein accumulation, the bacterial cells are harvested, lysed, and the A-chain and B-chain fusion proteins are extracted and purified from the bacterial lysate.
    *   The bacterial protein part (e.g., β-galactosidase) is then cleaved off, leaving behind pure A-chain and B-chain peptides.

6.  **Chemical Linking of A and B Chains:**
    *   The purified A-chain and B-chain peptides are then chemically combined *in vitro* (outside the living organism) by forming disulfide bonds between specific cysteine residues.
    *   This precise chemical linkage results in the formation of a fully functional, mature human insulin molecule.

7.  **Quality Control, Formulation, and Packaging:**
    *   The recombinant human insulin undergoes rigorous quality control checks to ensure its purity, potency, and safety.
    *   Finally, it is formulated into a stable pharmaceutical product and packaged for medical use.

Question 3

Q3. Discuss with your teacher and find out how to distinguish between a plasmid DNA and chromosomal DNA.

Accepted Answer

Plasmid DNA and chromosomal DNA are both forms of DNA found in bacterial cells, but they differ significantly in their structure, function, and properties. Here's how they can be distinguished:

| Feature             | Plasmid DNA                                    | Chromosomal DNA                                    |
| :------------------ | :--------------------------------------------- | :------------------------------------------------- |
| **Location**        | Extrachromosomal (outside the main chromosome) | Main genetic material within the nucleoid region   |
| **Size**            | Relatively small (a few thousand to hundreds of kilobases) | Very large (several million base pairs)            |
| **Shape**           | Typically circular, double-stranded            | Typically circular (in prokaryotes), double-stranded, highly supercoiled | | **Number per cell** | Variable (1 to hundreds, depending on the plasmid and cell type) | Usually one (in prokaryotes)                       |
| **Essentiality**    | Non-essential for basic cell survival and reproduction, but can confer advantageous traits | Essential for cell survival, contains genes for all vital functions | | **Replication**     | Replicates independently of the host chromosome, often with its own origin of replication | Replicates once per cell division, under strict cellular control | | **Gene Content**    | Carries 'accessory' genes (e.g., antibiotic resistance, virulence factors, metabolic pathways) | Carries 'housekeeping' genes essential for basic cellular processes | | **Transferability** | Can be easily transferred between bacteria (conjugation, transformation) | Generally not transferable between cells (except during cell division) | | **Manipulation**    | Easily isolated, manipulated, and used as vectors in genetic engineering | Difficult to isolate and manipulate due to large size and complexity |

Question 4

Q4. Match the following:
(a) Plasmid (i) selectable marker
(b) Exonuclease (ii) making cuts at specific positions
(c) Restriction endonuclease (iii) outside the DNA
(d) Ligase (iv)

Accepted Answer

Here are the correct matches:

(a) **Plasmid** - (v) Extrachromosomal DNA
(b) **Exonuclease** - (iii) outside the DNA
(c) **Restriction endonuclease** - (ii) making cuts at specific positions
(d) **Ligase** - (iv) joining of DNA fragments
(e) **EcoRI** - (ii) making cuts at specific positions (EcoRI is a type of restriction endonuclease)
(f) **pBR322** - (vi) vector (pBR322 is a commonly used plasmid vector)

Question 5

Q5. Write short notes on:
(a) Origin of replication
(b) Bioreactors
(c) Downstream processing

Accepted Answer

Here are short notes on the given topics:

**(a) Origin of Replication (ori)**

*   **Definition:** The origin of replication (ori) is a specific DNA sequence in a genome or plasmid where DNA replication is initiated. It is a crucial component of any vector used in recombinant DNA technology.
*   **Function in Vectors:** In the context of cloning vectors (like plasmids), the 'ori' sequence is responsible for controlling the number of copies of the linked DNA (the cloned gene) within the host cell. If a foreign piece of DNA is linked to the 'ori' sequence, it can replicate and multiply within the host cell.
*   **Copy Number Control:** The 'ori' sequence determines the copy number of the plasmid per cell. High copy number plasmids have 'ori' sequences that allow for many copies, while low copy number plasmids have 'ori' sequences that restrict the number of copies.
*   **Significance:** Without an 'ori' sequence, a foreign DNA fragment inserted into a vector would not be able to replicate independently within the host cell, making cloning and amplification impossible. It ensures that the recombinant DNA is stably maintained and propagated in the host.

**(b) Bioreactors**

*   **Definition:** Bioreactors are large vessels (typically 100 to 1000 litres capacity) used for the biological conversion of raw materials into specific products (e.g., proteins, enzymes, vaccines, antibiotics) using microbial, plant, or animal cells. They provide optimal conditions for the growth and activity of these cells.
*   **Purpose:** The primary goal of a bioreactor is to provide an optimal environment for the growth of the desired cells/microorganisms and the production of the target product in large quantities. This involves maintaining specific temperature, pH, substrate concentration, salts, vitamins, and oxygen levels.
*   **Types:** The most commonly used bioreactors are stirred-tank bioreactors (simple stirred-tank and sparged stirred-tank). These are designed for good mixing and oxygen availability.
*   **Key Components (Stirred-Tank Bioreactor):**
    *   **Agitator System:** For uniform mixing of contents (reactants and products) and ensuring oxygen availability throughout the culture.
    *   **Oxygen Delivery System:** To supply sterile air/oxygen.
    *   **Foam Control System:** To manage foam generated during agitation and aeration.
    *   **Temperature Control System:** To maintain optimal temperature.
    *   **pH Control System:** To maintain optimal pH (using acid/base addition).
    *   **Sampling Ports:** To withdraw small volumes of culture periodically for analysis.
*   **Advantages:** Allow for large-scale production, precise control over environmental conditions, and sterile operation.

**(c) Downstream Processing**

*   **Definition:** Downstream processing refers to the series of separation and purification steps required to recover and purify a biotechnological product (e.g., a recombinant protein, enzyme, or antibiotic) from the bioreactor culture broth after the biosynthetic stage.
*   **Importance:** Biosynthetic products are often produced in dilute concentrations within a complex mixture of cells, cell debris, unreacted substrates, and other metabolic by-products. Downstream processing is crucial to isolate the desired product in a highly pure form suitable for its intended use (e.g., pharmaceutical, food, industrial).
*   **Steps Involved:** The exact steps vary depending on the product and its properties, but generally include:
    1.  **Separation/Isolation:** Removing cells or cell debris from the culture broth (e.g., centrifugation, filtration).
    2.  **Purification:** Isolating the desired product from other soluble components (e.g., chromatography, precipitation, solvent extraction).
    3.  **Concentration:** Increasing the concentration of the purified product.
    4.  **Formulation:** Adding suitable preservatives and stabilizers to the product.
    5.  **Quality Control:** Rigorous testing for purity, potency, safety, and efficacy.
*   **Significance:** Downstream processing is a critical and often expensive part of the overall bioprocess, sometimes accounting for 50-80% of the total production cost. It ensures that the final product meets regulatory standards and is safe and effective for its intended application.

Question 6

Q6. Can you think and answer how a reporter enzyme can be used to monitor transformation of host cells by foreign DNA?

Accepted Answer

A reporter enzyme is used to monitor the transformation of host cells by foreign DNA, particularly to distinguish between transformed and non-transformed cells, and often to identify recombinant cells (those that have incorporated the foreign DNA of interest) from non-recombinant transformed cells. This is typically achieved through a process called insertional inactivation, often using a chromogenic substrate.

**Mechanism using lacZ gene as a reporter:**
1.  **Cloning Vector Design:** A common strategy involves using a cloning vector (e.g., pUC18) that contains a gene encoding a reporter enzyme, such as the *lacZ* gene, which codes for beta-galactosidase. This *lacZ* gene is placed within a multiple cloning site (MCS) or polylinker region.
2.  **Beta-galactosidase Activity:** When the *lacZ* gene is intact and expressed, the beta-galactosidase enzyme is produced. This enzyme can hydrolyze a chromogenic substrate, like X-gal (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside), present in the culture medium, producing a blue-colored product.
3.  **Transformation:** Host cells (e.g., *E. coli*) are transformed with the recombinant DNA (vector + foreign DNA insert) or non-recombinant vector.
4.  **Screening for Transformants:** Cells are plated on an agar medium containing an antibiotic (e.g., ampicillin, if the vector has an ampicillin resistance gene) and X-gal.
    *   **Non-transformed cells:** These cells will not have the antibiotic resistance gene from the vector and will die on the antibiotic-containing medium.
    *   **Transformed cells:** These cells will survive due to the antibiotic resistance gene carried by the vector.
5.  **Screening for Recombinants (Insertional Inactivation):** Among the transformed cells, we need to identify those that have successfully incorporated the foreign DNA into the vector.
    *   **Recombinant cells:** If the foreign DNA is successfully ligated into the MCS within the *lacZ* gene, it disrupts the gene's coding sequence. This is called insertional inactivation. As a result, the *lacZ* gene cannot produce functional beta-galactosidase. When these cells are grown on X-gal medium, they will not produce the blue color and will appear as **white colonies**.
    *   **Non-recombinant transformed cells:** If the vector re-ligates without incorporating the foreign DNA insert, the *lacZ* gene remains intact and functional. These cells will produce beta-galactosidase, which hydrolyzes X-gal, resulting in **blue colonies**.

By observing the color of the colonies, researchers can easily distinguish between transformed cells containing the desired foreign DNA insert (white colonies) and those containing only the self-ligated vector (blue colonies). This method is known as **blue-white screening**.

Question 7

Q7. Can you think of a situation where a foreign DNA fragment is inserted into a plasmid, but it does not get expressed? Discuss with your teacher.

Accepted Answer

Yes, there are several situations where a foreign DNA fragment, even if successfully inserted into a plasmid, might not get expressed in the host cell. The expression of a gene is a complex process requiring specific regulatory signals and cellular machinery. If any of these components are missing or improperly configured, expression will fail.

### Reasons for Non-Expression of a Foreign DNA Fragment:

1.  **Absence of a Suitable Promoter:**
    *   **Explanation:** Gene expression in both prokaryotes and eukaryotes is initiated by a promoter sequence, which is a DNA region that RNA polymerase binds to, to start transcription. If the foreign DNA fragment is inserted into the plasmid without a functional promoter sequence upstream of it, or if it is placed downstream of a promoter that is not recognized by the host cell's RNA polymerase, transcription will not occur, and thus no protein will be synthesized.
    *   **Example:** A eukaryotic gene inserted into a bacterial plasmid might not be expressed if it lacks a bacterial promoter (like lac promoter or trp promoter) that can be recognized by bacterial RNA polymerase.

2.  **Incorrect Reading Frame:**
    *   **Explanation:** For a gene to be translated into a functional protein, the ribosome must start translation at the correct start codon (usually AUG) and read the mRNA in the correct triplet sequence (reading frame). If the foreign DNA is inserted in such a way that it shifts the reading frame (e.g., by adding or deleting nucleotides not in multiples of three, or by inserting it out of frame with an existing start codon), it will lead to the production of a non-functional, truncated, or entirely different protein due to premature stop codons or altered amino acid sequences.

3.  **Absence of a Ribosome Binding Site (RBS) / Shine-Dalgarno Sequence:**
    *   **Explanation:** In prokaryotes, a specific sequence called the Shine-Dalgarno sequence (or RBS) upstream of the start codon is essential for the ribosome to bind to the mRNA and initiate translation. If the foreign gene lacks this sequence or if it's not positioned correctly relative to the start codon, ribosomes will not be able to efficiently bind and translate the mRNA.

4.  **Presence of an Early Stop Codon:**
    *   **Explanation:** If, due to an incorrect insertion or mutation, a stop codon (UAA, UAG, UGA) appears prematurely within the coding sequence of the foreign gene, translation will terminate prematurely, resulting in a truncated and usually non-functional protein.

5.  **Unfavorable Host Environment:**
    *   **Explanation:** The host cell might lack the necessary cellular machinery or conditions required for the proper expression, folding, or modification of the foreign protein. For example:
        *   **Lack of specific tRNAs:** If the foreign gene uses codons that are rare in the host organism, the host might not have sufficient amounts of the corresponding tRNAs, leading to slow or incomplete translation.
        *   **Protease activity:** The host cell might contain proteases that degrade the foreign protein rapidly.
        *   **Lack of post-translational modification machinery:** Eukaryotic proteins often require specific post-translational modifications (e.g., glycosylation, phosphorylation, disulfide bond formation) for their activity and stability. If a eukaryotic gene is expressed in a prokaryotic host, these modifications might not occur, leading to an inactive protein.

6.  **Insertion into a Non-coding or Silent Region:**
    *   **Explanation:** If the foreign DNA fragment is inserted into a region of the plasmid that is transcriptionally inactive or into a region that is rapidly silenced by the host cell's regulatory mechanisms, it will not be expressed.

7.  **Instability of the Recombinant Protein:**
    *   **Explanation:** Even if transcribed and translated, the foreign protein might be unstable in the host cell environment due to improper folding, aggregation (forming inclusion bodies), or susceptibility to host proteases, leading to its rapid degradation.

In conclusion, successful expression of a foreign gene in a host cell requires careful consideration of the genetic elements (promoter, RBS, correct reading frame, terminator) and the compatibility between the foreign gene and the host cell's molecular machinery and environment. Genetic engineering strategies often involve using expression vectors specifically designed to overcome these challenges.

Question 8

Q8. What would be the advantages of using a bioreactor?

Accepted Answer

Bioreactors are large vessels (typically 100-1000 litres capacity) used for the large-scale production of biotechnological products such as enzymes, proteins, vaccines, antibiotics, and other biomolecules. They provide an optimal environment for the growth of microbial, plant, or animal cells and for the conversion of raw materials into desired products. The advantages of using a bioreactor over small-scale laboratory cultures are significant:

### Advantages of Using a Bioreactor:

1.  **Large-Scale Production:** Bioreactors enable the cultivation of large volumes of cell cultures, leading to the production of substantial quantities of the desired product. This is crucial for industrial applications where high yields are necessary to meet market demand.

2.  **Maintenance of Optimal Growth Conditions:** Bioreactors are designed to provide and precisely control the ideal physical and chemical conditions required for the growth of the host organism and the synthesis of the product. These conditions include:
    *   **Temperature:** Controlled by a heating/cooling system.
    *   **pH:** Monitored by pH probes and adjusted automatically using acid/base addition systems.
    *   **Substrate/Nutrient Supply:** Continuous or fed-batch supply of raw materials (carbon source, nitrogen source, minerals, vitamins) ensures sustained cell growth and product formation.
    *   **Oxygen Availability:** For aerobic processes, oxygen is sparged through the culture broth, and its availability is monitored and regulated to prevent oxygen limitation, which can hinder cell growth and product yield.
    *   **Salts and Vitamins:** Essential micronutrients are supplied to support metabolic activities.

3.  **Sterile Environment:** Bioreactors are designed to maintain aseptic (sterile) conditions throughout the fermentation process. This prevents contamination by unwanted microorganisms, which could compete with the desired culture, degrade the product, or produce undesirable by-products, thereby ensuring product purity and process efficiency.

4.  **Efficient Mixing and Aeration:** Stirred-tank bioreactors are equipped with an agitator system (impeller) that ensures uniform mixing of the culture broth. This uniform mixing facilitates:
    *   Homogeneous distribution of nutrients and oxygen throughout the culture.
    *   Even distribution of cells.
    *   Efficient heat transfer, preventing localized overheating.
    *   Effective removal of metabolic waste products.

5.  **Foam Control:** Many fermentation processes generate foam, which can reduce the working volume, cause contamination, and hinder gas exchange. Bioreactors often include foam breakers or antifoam agent addition systems to manage foam effectively.

6.  **Sampling Ports:** Bioreactors are fitted with sampling ports that allow periodic withdrawal of small volumes of culture broth without compromising sterility. This enables monitoring of cell growth, substrate consumption, product formation, and other critical parameters throughout the fermentation process.

7.  **Automated Control Systems:** Modern bioreactors are integrated with sophisticated computer-controlled systems that allow for real-time monitoring and automatic adjustment of various parameters (temperature, pH, dissolved oxygen, agitation speed). This automation reduces manual intervention, increases precision, and optimizes process efficiency.

8.  **Higher Yields and Product Quality:** By providing optimal and controlled conditions, bioreactors maximize the metabolic activity of the cells, leading to higher yields of the desired product. The controlled environment also contributes to better product quality and consistency.

In summary, bioreactors are indispensable tools in industrial biotechnology, transforming laboratory-scale research into commercially viable production by providing a controlled, sterile, and optimized environment for large-scale bioprocessing.

Question 9

Q9. Collect 5 examples of palindromic DNA sequences by consulting your teacher. Better try to create some by following the rules.

Accepted Answer

A palindromic DNA sequence is a sequence of nucleotides that reads the same on both strands when the orientation of reading is kept the same (i.e., 5' to 3'). These sequences are typically recognized by restriction enzymes, which cut the DNA at or near these sites.

### Rules for Creating Palindromic DNA Sequences:
1.  The sequence must be double-stranded DNA.
2.  Read the top strand from 5' to 3'.
3.  Read the bottom strand from 5' to 3'.
4.  The sequence on the top strand (5' to 3') must be identical to the sequence on the bottom strand (5' to 3').

### 5 Examples of Palindromic DNA Sequences (Recognition Sites for Restriction Enzymes):

1.  **EcoRI (from *Escherichia coli* RY13):**
    5' - G A A T T C - 3'
    3' - C T T A A G - 5'
    (Reads GAATTC from 5' to 3' on both strands)

2.  **HindIII (from *Haemophilus influenzae* Rd):**
    5' - A A G C T T - 3'
    3' - T T C G A A - 5'
    (Reads AAGCTT from 5' to 3' on both strands)

3.  **BamHI (from *Bacillus amyloliquefaciens* H):**
    5' - G G A T C C - 3'
    3' - C C T A G G - 5'
    (Reads GGATCC from 5' to 3' on both strands)

4.  **SmaI (from *Serratia marcescens*):**
    5' - C C C G G G - 3'
    3' - G G G C C C - 5'
    (Reads CCCGGG from 5' to 3' on both strands)

5.  **AluI (from *Arthrobacter luteus*):**
    5' - A G C T - 3'
    3' - T C G A - 5'
    (Reads AGCT from 5' to 3' on both strands)

### How to Create Your Own Palindromic Sequence:
1.  Choose a short sequence of nucleotides for the 5' to 3' direction of the top strand (e.g., 5'-ATGC-3').
2.  Write its complementary sequence in the 3' to 5' direction below it (e.g., 3'-TACG-5').
3.  Now, to make it palindromic, the sequence you chose for the top strand (5'-ATGC-3') must be the same as the sequence of the bottom strand when read from 5' to 3'.
    *   Let's take the example: 5'-ATGC-3'. Its complement is 3'-TACG-5'.
    *   If we read the bottom strand from 5' to 3', it would be 5'-GCAT-3'.
    *   Since 5'-ATGC-3' is not the same as 5'-GCAT-3', this is not a palindrome.
4.  To create a palindrome, pick a sequence for the top strand (e.g., 5'-AGCT-3').
5.  Now, write its complementary sequence, but ensure that when you read the bottom strand from 5' to 3', it matches the top strand's 5' to 3' sequence.
    *   Top strand (5' to 3'): A G C T
    *   Complementary bottom strand (3' to 5'): T C G A
    *   Now, read the bottom strand from 5' to 3': A G C T
    *   Since 5'-AGCT-3' (top) matches 5'-AGCT-3' (bottom), this is a palindrome.

This demonstrates that the sequence on one strand, when read 5' to 3', is identical to the sequence on the complementary strand when also read 5' to 3'.

Question 10

Q10. Digestion of DNA by restriction endonucleases results in a fragment. Name the technique to separate it.

Accepted Answer

The technique used to separate DNA fragments resulting from digestion by restriction endonucleases is **Agarose Gel Electrophoresis**.

**Principle:**
Agarose gel electrophoresis separates DNA fragments based on their size and charge. DNA molecules are negatively charged due to their phosphate groups. When placed in an electric field, they migrate towards the positive electrode (anode). The agarose gel acts as a sieve, allowing smaller fragments to move faster and further through the pores of the gel, while larger fragments move slower and lag behind.

**Process:**
1.  **Gel Preparation:** An agarose gel is prepared by dissolving agarose powder in a buffer solution and pouring it into a mold with a comb inserted to create wells.
2.  **Loading DNA:** The DNA fragments (mixed with a loading dye for visibility) are loaded into the wells at the negative electrode end of the gel.
3.  **Electrophoresis:** An electric current is applied across the gel. DNA fragments migrate through the gel matrix towards the positive electrode.
4.  **Separation:** Over time, the DNA fragments separate into distinct bands according to their size. A DNA ladder (fragments of known sizes) is run alongside the samples to estimate the sizes of the unknown fragments.
5.  **Visualization:** After electrophoresis, the gel is stained with a DNA-binding dye (e.g., ethidium bromide). When exposed to UV light, the DNA bands fluoresce (appear as bright orange bands), allowing them to be visualized and photographed.
6.  **Elution (Gene Extraction):** The desired DNA band can then be cut out from the gel and extracted (eluted) for further use, such as cloning or sequencing. This process is called **elution**.

Question 11

Q11. Discuss with your teacher and find out how to distinguish between an exonuclease and an endonuclease.

Accepted Answer

Exonucleases and endonucleases are both types of nucleases, which are enzymes that cleave the phosphodiester bonds within nucleic acid molecules (DNA or RNA). The primary distinction between them lies in their site of action on the nucleic acid strand.

### Distinguishing Between Exonuclease and Endonuclease:

| Feature             | Exonuclease                                         | Endonuclease                                         |
| :------------------ | :-------------------------------------------------- | :--------------------------------------------------- |
| **Site of Action**  | Cleaves nucleotides from the **ends** of a DNA or RNA strand. | Cleaves phosphodiester bonds at **internal positions** within a DNA or RNA strand. |
| **Mode of Action**  | Removes nucleotides one by one sequentially from either the 5' or 3' end. | Makes cuts within the polynucleotide chain, creating fragments. |
| **Specificity**     | Generally less specific in terms of sequence recognition; acts on any terminal nucleotide. | Highly specific; recognizes and cuts at particular nucleotide sequences (recognition sites). |\ | **Products**        | Shortens the nucleic acid molecule from the ends.   | Breaks the nucleic acid into smaller fragments.      |\ | **Role in DNA Repair** | Involved in proofreading and removal of mismatched bases from ends. | Involved in excision repair (removing damaged internal segments). |\ | **Examples**        | DNA Polymerase I (3'→5' exonuclease activity), Exonuclease III, Lambda exonuclease. | Restriction Endonucleases (e.g., EcoRI, HindIII), DNase I, RNase H. |\ | **Application in Genetic Engineering** | Less commonly used for precise DNA cutting; more for DNA degradation or removal of specific ends. | Indispensable for genetic engineering to cut DNA at specific sites, creating sticky or blunt ends for cloning. |

In summary, exonucleases act like 'trimmers' that remove nucleotides from the ends of a nucleic acid strand, while endonucleases act like 'scissors' that make precise cuts within the strand, often at specific recognition sequences. Restriction endonucleases are a particularly important class of endonucleases widely used in recombinant DNA technology.

Question 12

Q12. Discuss with your teacher and find out how to distinguish between an exonuclease and an endonuclease.

Accepted Answer

Exonucleases and endonucleases are both types of nucleases, enzymes that cleave the phosphodiester bonds of nucleic acids (DNA or RNA). The primary distinction between them lies in their site of action on the nucleic acid strand.

1.  **Exonucleases:**
    *   **Definition:** These enzymes remove nucleotides one by one from the *ends* (either 5' or 3') of a DNA or RNA molecule.
    *   **Mode of Action:** They act on the terminal phosphodiester bonds. They cannot cut within the internal part of a nucleic acid strand.
    *   **Example:** Exonuclease III, Bal31 nuclease.

2.  **Endonucleases:**
    *   **Definition:** These enzymes cleave phosphodiester bonds *within* a DNA or RNA molecule, rather than at the ends.
    *   **Mode of Action:** They can cut at specific or non-specific sites internally. Restriction endonucleases are a specific type of endonuclease that recognize and cut DNA at specific palindromic sequences.
    *   **Example:** Restriction endonucleases (e.g., EcoRI, HindIII), DNase I.

**Key Distinguishing Feature:**
The fundamental difference is their site of action: **exonucleases cut from the ends, while endonucleases cut within the DNA strand.**

Question 13

Q13. Describe the role of selectable marker in the selection of transformed cells.

Accepted Answer

In recombinant DNA technology, the process of introducing foreign DNA into a host cell is called **transformation**. Not all host cells take up the foreign DNA (vector), and even among those that do, some might take up non-recombinant vectors (vector without the insert) while others take up recombinant vectors (vector with the desired gene insert). A **selectable marker** is a crucial component of a cloning vector that helps in identifying and selecting these transformed cells from the non-transformed ones, and often, also distinguishing between recombinant and non-recombinant transformants.

### 1. Definition and Primary Functions
A selectable marker is a gene present in the cloning vector that confers a specific phenotype (usually resistance to an antibiotic or ability to grow on a specific medium) to the host cell that has successfully taken up the vector. Its primary functions are:
*   **Identification of Transformants:** To select cells that have successfully incorporated the foreign DNA (vector) from those that have not.
*   **Elimination of Non-transformants:** To kill or inhibit the growth of non-transformed host cells.

### 2. Mechanism of Selection (Antibiotic Resistance)
Common selectable markers include genes encoding resistance to antibiotics like ampicillin (amp^R), chloramphenicol, tetracycline (tet^R), or kanamycin.
*   **Process:** Host cells (e.g., *E. coli*) are typically sensitive to these antibiotics. The cloning vector (e.g., pBR322) carries genes for antibiotic resistance. After transformation, the cells are plated on a medium containing one of these antibiotics (e.g., ampicillin). Only the cells that have successfully taken up the plasmid (transformants) will survive and grow because they express the antibiotic resistance gene. Non-transformed cells, lacking the plasmid, will be killed by the antibiotic.

### 3. Distinguishing Recombinants from Non-Recombinants (Insertional Inactivation)
Selectable markers can also be used to differentiate between cells that have taken up a recombinant plasmid (vector with the desired gene insert) and those that have taken up a non-recombinant plasmid (vector without the insert). This is often achieved through a process called **insertional inactivation**.

*   **Example: pBR322 with Tetracycline Resistance:**
    1.  The pBR322 vector has two antibiotic resistance genes: amp^R and tet^R.
    2.  If a foreign DNA fragment is ligated into a restriction site *within* the tet^R gene (e.g., BamHI site), the insertion will disrupt the tet^R gene, making it non-functional. This is insertional inactivation.
    3.  Transformed cells are first plated on a medium containing ampicillin. All transformants (both recombinant and non-recombinant) will grow.
    4.  These colonies are then replica-plated onto a medium containing tetracycline.
        *   **Non-recombinant transformants:** Will grow on both ampicillin and tetracycline plates (as both amp^R and tet^R genes are intact).
        *   **Recombinant transformants:** Will grow on the ampicillin plate but *not* on the tetracycline plate (because the tet^R gene is inactivated by the inserted DNA).
    5.  By comparing the two plates, recombinant colonies can be identified and selected.

*   **Example: Blue-White Screening (LacZ gene):**
    1.  Many modern vectors use the *lacZ* gene as a selectable marker. This gene encodes β-galactosidase, an enzyme that can hydrolyze a chromogenic substrate (e.g., X-gal) to produce a blue-colored product.
    2.  The cloning site is located within the *lacZ* gene.
    3.  If foreign DNA is inserted into the *lacZ* gene, it inactivates the gene (insertional inactivation), preventing the production of functional β-galactosidase.
    4.  Transformed cells are grown on a medium containing X-gal and an inducer (e.g., IPTG).
        *   **Non-recombinant transformants:** Have an intact *lacZ* gene, produce β-galactosidase, and form blue colonies.
        *   **Recombinant transformants:** Have an inactivated *lacZ* gene, do not produce functional β-galactosidase, and form white colonies.
    5.  Thus, white colonies are selected as recombinants.

In summary, selectable markers are indispensable tools in genetic engineering, enabling the efficient isolation of desired transformed cells and recombinant clones, which is critical for the success of any gene cloning experiment.

Question 14

Q14. Describe briefly the following:
(a) Origin of replication
(b) Bioreactors
(c) Downstream processing

Accepted Answer

### (a) Origin of Replication (ori)

The origin of replication, or 'ori', is a specific sequence of nucleotides in a DNA molecule at which replication is initiated.

**Key Features and Importance in Biotechnology:**
1.  **Initiation of Replication:** For any piece of alien DNA to replicate within a host cell, it must be linked to a vector that contains an origin of replication. This sequence is recognized by the host cell's DNA polymerase, which then initiates the replication process.
2.  **Autonomous Replication:** The presence of an 'ori' allows the plasmid vector (and the inserted gene) to replicate independently of the host's chromosomal DNA.
3.  **Copy Number Control:** The 'ori' sequence is also responsible for controlling the copy number of the linked DNA (i.e., the number of copies of the plasmid per host cell). If the goal is to obtain a large quantity of a protein product, the gene of interest should be cloned into a vector whose 'ori' supports a high copy number, leading to many copies of the gene and consequently, a high yield of the protein.

### (b) Bioreactors

Bioreactors are large-volume (100-1000 litres) vessels designed to carry out biological reactions under controlled conditions. They are used for growing microorganisms (like bacteria, yeast) or cells (plant, animal) on a large scale to produce specific products like enzymes, proteins, antibiotics, beverages, etc.

**Key Features:**
A bioreactor provides the optimal growth conditions for achieving the desired product. These include:
*   **Agitator System:** For uniform mixing of contents and oxygen.
*   **Oxygen Delivery System:** To provide sufficient oxygen for aerobic processes.
*   **Foam Control System:** To prevent foam formation, which can interfere with the process.
*   **Temperature Control System:** To maintain the optimal temperature for cell growth and product formation.
*   **pH Control System:** To maintain the optimal pH.
*   **Sampling Ports:** To withdraw small volumes of the culture periodically for testing.

**Types of Bioreactors:**
1.  **Simple Stirred-Tank Bioreactor:** It is usually cylindrical with a curved base to facilitate the mixing of the reactor contents. A stirrer with impellers ensures even mixing and oxygen availability throughout the bioreactor.
2.  **Sparged Stirred-Tank Bioreactor:** In this type, sterile air is bubbled (sparged) through the culture medium. This dramatically increases the surface area for oxygen transfer, which is often a limiting factor in large-scale cultures.

### (c) Downstream Processing

Downstream processing refers to the series of steps required for the recovery and purification of a biosynthetic product from natural sources such as animal or plant tissue or from fermentation broth, after the bioprocess (fermentation/biosynthesis) is complete.

**The main stages of downstream processing include:**
1.  **Separation (Harvesting):** The first step is to separate the product from the cell mass and other solid impurities. This is achieved by methods like centrifugation or filtration.
2.  **Purification:** The product is then purified from other molecules that were also present in the broth. This is a critical step and involves techniques like chromatography, solvent extraction, precipitation, etc., to achieve a high degree of purity.
3.  **Formulation:** The purified product is mixed with suitable preservatives and stabilizers to create a final, stable formulation. This is particularly important for therapeutic drugs.
4.  **Quality Control and Packaging:** The final product undergoes strict quality control tests to ensure its safety, efficacy, and purity. It is then filled into suitable containers and packaged for marketing. For pharmaceuticals, all these processes must be conducted under sterile conditions.

Downstream processing is a crucial and often expensive part of the overall production process, especially for therapeutic products.

Chapter 11: Biotechnology: Principles and Processes